Stay updated on Radiolabeled SNDX-5613 in Acute Leukemia Clinical Trial
Sign up to get notified when there's something new on the Radiolabeled SNDX-5613 in Acute Leukemia Clinical Trial page.

Latest updates to the Radiolabeled SNDX-5613 in Acute Leukemia Clinical Trial page
- Check5 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.4.2 was added to the site footer, and the previous funding-status notice along with Revision: v3.4.1 were removed.SummaryDifference0.5%

- Check40 days agoChange DetectedA site-wide notice about government funding and a version update (v3.4.1) were added; the study details and data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check47 days agoChange DetectedAdded a glossary toggle and updated QC metadata (Last Update Submitted that Met QC Criteria and Revision: v3.4.0). Removed the older QC heading, No FEAR Act data label, and the previous Revision value (v3.3.4).SummaryDifference0.2%

- Check61 days agoChange DetectedFooter revision updated to v3.3.4, replacing v3.3.3. This appears to be a minor site update that does not affect the study details.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now lists a Texas location (Houston, MD Anderson Cancer Center) under Locations. The HHS Vulnerability Disclosure link was removed and the page revision shows v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Radiolabeled SNDX-5613 in Acute Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiolabeled SNDX-5613 in Acute Leukemia Clinical Trial page.